A detailed history of Fmr LLC transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 8,676,723 shares of ZNTL stock, worth $33.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,676,723
Previous 10,644,024 18.48%
Holding current value
$33.1 Million
Previous $168 Million 78.85%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$4.09 - $16.13 $8.05 Million - $31.7 Million
-1,967,301 Reduced 18.48%
8,676,723 $35.5 Million
Q1 2024

May 13, 2024

BUY
$10.83 - $16.49 $3.33 Million - $5.06 Million
307,053 Added 2.97%
10,644,024 $168 Million
Q4 2023

Feb 13, 2024

BUY
$9.84 - $20.13 $8.3 Million - $17 Million
843,075 Added 8.88%
10,336,971 $157 Million
Q3 2023

Nov 13, 2023

SELL
$19.63 - $28.29 $21.3 Million - $30.6 Million
-1,082,676 Reduced 10.24%
9,493,896 $190 Million
Q2 2023

Aug 11, 2023

BUY
$17.41 - $30.05 $29 Million - $50 Million
1,663,821 Added 18.67%
10,576,572 $298 Million
Q1 2023

May 11, 2023

BUY
$16.14 - $24.94 $16.2 Million - $25 Million
1,003,575 Added 12.69%
8,912,751 $153 Million
Q4 2022

Feb 13, 2023

BUY
$18.07 - $25.6 $6.14 Million - $8.69 Million
339,570 Added 4.49%
7,909,176 $159 Million
Q3 2022

Nov 10, 2022

SELL
$20.23 - $31.73 $4.18 Million - $6.55 Million
-206,562 Reduced 2.66%
7,569,606 $164 Million
Q2 2022

Aug 12, 2022

BUY
$17.91 - $52.25 $18.5 Million - $54 Million
1,033,474 Added 15.33%
7,776,168 $219 Million
Q1 2022

May 13, 2022

SELL
$41.58 - $80.89 $2.21 Million - $4.3 Million
-53,137 Reduced 0.78%
6,742,694 $311 Million
Q4 2021

Feb 14, 2022

BUY
$66.92 - $84.79 $2.54 Million - $3.21 Million
37,896 Added 0.56%
6,795,831 $571 Million
Q3 2021

Nov 15, 2021

BUY
$46.83 - $73.5 $4.48 Million - $7.03 Million
95,710 Added 1.44%
6,757,935 $450 Million
Q2 2021

Aug 13, 2021

BUY
$37.41 - $62.25 $249 Million - $415 Million
6,662,225 New
6,662,225 $354 Million

Others Institutions Holding ZNTL

About Zentalis Pharmaceuticals, Inc.


  • Ticker ZNTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,983,600
  • Market Cap $217M
  • Description
  • Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...
More about ZNTL
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.